Ab1677 #ACR22 by @MaxKonigMD Chimeric autoAg T cell recepter (CATCR) reprogram T cells to selectively kill autoreactive B cells Model CATCR for APLS via B2GPI-CATCR T-cells eliminating anti-B2GP DI B cells, dose-dependent Model for SELECTIVE Rx in APLS/rheum disease @RheumNow https://t.co/jMpMu10phL